출판 : MarketsandMarkets (마켓츠앤마켓츠) 출판년월 : 2022년11월
마이크로카테터(Microcatheter) 시장 : 유형 (배달, 진단, 흡입, 조종 가능), 디자인 (단일, 이중), 용도 (심혈관, 신경 혈관, 말초 혈관, 종양학), 최종 사용자 (병원, 외래 수술 센터) – 2027 년까지의 세계 예측
Microcatheter Market by Type (Delivery, Diagnostic, Aspiration, Steerable), Design (Single, Dual), Application (Cardiovascular, Neurovascular, Peripheral Vascular, Oncology), End-User (Hospital and Ambulatory Surgical Centers) – Global Forecasts to 2027
| 페이지수 | 165 |
| 도표수 | 149 |
| 구성 | 영문조사보고서 |
| 가격 |
The global microcatheter market is projected to reach USD 1,082 million by 2027 from USD 828 million in 2022, at a CAGR of 5.5% during the forecast period. Factors such as the growing adoption of minimally invasive procedures, rising geriatric individuals, Increasing prevalence of cardiovascular and neurovascular diseases, and increasing sedentary lifestyles and eating habits are increasing cardiac arrest cases, thereby increasing the minimally invasive procedures in hospitals.
글로벌 마이크로카테터 시장은 예측 기간 동안 5.5%의 CAGR로 성장하여 2022년 USD 8억 2800만 달러에서 2027년까지 USD 10억 8200만 달러에 이를 것으로 예상됩니다. 최소 침습적 시술의 채택 증가, 노인 인구 증가, 심혈관 및 신경혈관 질환의 유병률 증가, 좌식 생활 습관 및 식습관 증가와 같은 요인으로 인해 심정지 사례가 증가하여 병원에서 최소 침습적 시술이 증가하고 있습니다.
“The delivery microcatheter to hold the largest share of the market in 2022”
The delivery microcatheter holds the largest market share in 2022. The large share of this segment can be attributed to knowing the use of the microcatheter properly and the increasing number of nonsurgical procedures replacing open surgeries.
“The clinics, hospitals, and medical spas segment is projected to register the highest CAGR during the forecast period”
Based on end users, the microcatheter market is segmented into hospitals, Surgical centers, and Specialty clinics. The hospitals, Surgical centers, and Specialty clinics are projected to register the highest CAGR during the forecast period of 2022 to 2027. The key factors supporting segment growth are the availability of high-quality non-surgical equipment and personnel in hospitals, growing awareness about minimally invasive procedures performed in hospital settings, and the increasing number of plastic surgeons.
“The market in North America region is expected to witness the highest growth during the forecast period.”
North America accounted for the largest market share—46.4%—in 2022. This share can be attributed to a large number of target procedures (including cardiovascular, neurovascular, and oncology, among others) performed in the region coupled with the high prevalence of related diseases & disorders. In addition, the presence of a well-established healthcare system in the US and ongoing investments by hospitals to upgrade & expand operating capabilities are some of the other factors expected to fuel the growth of the microcatheters market in North America.
While growth in the US and European markets for microcatheters is reaching stagnancy due to market saturation, the market in the APAC is expected to witness significant growth in the coming years. The microcatheters market in the APAC region is expected to register a CAGR of 6.9% during the forecast period, primarily due to the growing number of hospitals in Asian countries, favorable government initiatives, growing healthcare industry, and increasing prevalence of target diseases & disorders in the region.
A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–30%, Tier 2–42%, and Tier 3– 28%
• By Designation: C-level–10%, Director-level–76%, and Others–14%
• By Region: North America–40%, Europe–30%, Asia Pacific–22%, Latin America–6%, and the Middle East & Africa–2%
The prominent players in the microcatheter market Boston Scientific Corporation. (US), Stryker Corporation (US), Teleflex Incorporated (US), Cook Group (US), Becton Dickinson and Company (US), Asahi Intecc Co.ltd (Japan) among others.
Research Coverage
This report studies the microcatheter market based on product,product design, end user and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established and entrants/smaller firms to gauge the market’s pulse, which, in turn, would help them garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the microcatheter market.
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the microcatheter market..
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the microcatheter market.
• Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
목차
1 INTRODUCTION 24
1.1 STUDY OBJECTIVES 24
1.2 MARKET DEFINITION 24
1.2.1 INCLUSIONS AND EXCLUSIONS 24
1.3 MARKET SCOPE 25
1.3.1 MARKETS COVERED 25
FIGURE 1 MICROCATHETERS MARKET, BY SEGMENTATION 25
FIGURE 2 MICROCATHETERS MARKET, BY REGION 25
1.3.2 YEARS CONSIDERED 26
1.4 CURRENCY CONSIDERED 26
1.5 STAKEHOLDERS 26
1.6 SUMMARY OF CHANGES 27
2 RESEARCH METHODOLOGY 28
2.1 RESEARCH DATA 28
2.2 RESEARCH DESIGN 28
FIGURE 3 MICROCATHETERS MARKET: RESEARCH DESIGN 28
2.2.1 SECONDARY DATA 29
2.2.2 PRIMARY DATA 29
FIGURE 4 PRIMARY SOURCES 29
2.2.2.1 Key data from primary sources 30
2.2.2.2 Insights from primary experts 30
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS 31
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 31
2.3 MARKET SIZE ESTIMATION 31
FIGURE 7 SUPPLY SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 32
FIGURE 8 TOP-DOWN APPROACH 33
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 35
FIGURE 9 DATA TRIANGULATION METHODOLOGY 35
2.5 MARKET SHARE ESTIMATION 35
2.6 RESEARCH ASSUMPTIONS 36
2.7 STUDY LIMITATIONS 36
2.7.1 METHODOLOGY-RELATED LIMITATIONS 36
2.8 RISK ASSESSMENT 36
TABLE 1 LIMITATIONS AND ASSOCIATED RISKS 36
3 EXECUTIVE SUMMARY 37
FIGURE 10 MICROCATHETERS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 37
FIGURE 11 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2022 VS. 2027 (USD MILLION) 38
FIGURE 12 MICROCATHETERS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 38
FIGURE 13 MICROCATHETERS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 39
FIGURE 14 ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 39
4 PREMIUM INSIGHTS 41
4.1 MICROCATHETERS MARKET OVERVIEW 41
FIGURE 15 TECHNOLOGICAL ADVANCEMENTS AND RISING CHRONIC DISEASE INCIDENCE TO DRIVE DEMAND 41
4.2 MICROCATHETERS MARKET SHARE, BY COUNTRY AND PRODUCT 42
FIGURE 16 NORTH AMERICA TO HOLD LARGEST SHARE OF GLOBAL MARKET 42
4.3 MICROCATHETERS MARKET SHARE, BY END USER 42
FIGURE 17 HOSPITALS TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD 42
4.4 GEOGRAPHICAL SNAPSHOT OF MICROCATHETERS MARKET 43
FIGURE 18 INDIA TO GROW AT HIGHEST RATE DURING 2022–2027 43
5 MARKET OVERVIEW 44
5.1 INTRODUCTION 44
5.2 MARKET DYNAMICS 44
FIGURE 19 MICROCATHETERS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES 44
5.2.1 DRIVERS 45
5.2.1.1 Technological advancements in interventional cardiology 45
5.2.1.2 Expansion of patient population suffering from chronic illness 45
5.2.1.3 Increasing conferences and symposia to spread awareness about benefits of microcatheters 45
5.2.2 RESTRAINTS 46
5.2.2.1 Stringent regulatory guidelines and high cost of drug approval 46
5.2.2.2 Lack of awareness about microcatheters in underdeveloped or emerging countries 46
5.2.3 OPPORTUNITIES 46
5.2.3.1 Rising number of patients suffering from chronic diseases and cancer globally 46
5.3 KEY STAKEHOLDERS AND BUYING CRITERIA 47
5.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 47
FIGURE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICROCATHETERS MARKET 47
TABLE 2 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR MICROCATHETERS MARKET 47
5.4 PORTER’S FIVE FORCES ANALYSIS 47
5.4.1 OVERVIEW 47
TABLE 3 MICROCATHETERS MARKET: PORTER’S FIVE FORCES ANALYSIS 48
5.4.2 THREAT OF NEW ENTRANTS 48
5.4.3 THREAT OF SUBSTITUTES 48
5.4.4 BARGAINING POWER OF SUPPLIERS 48
5.4.5 BARGAINING POWER OF BUYERS 48
5.4.6 DEGREE OF COMPETITION 49
5.5 REGULATORY ANALYSIS 49
5.5.1 US 49
TABLE 4 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 50
5.5.2 EUROPE 50
5.5.3 JAPAN 50
TABLE 5 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 51
5.6 REIMBURSEMENT ANALYSIS 51
TABLE 6 CPT CODES FOR MAJOR MICROCATHETERS 51
5.7 ECOSYSTEM ANALYSIS 52
5.8 VALUE CHAIN ANALYSIS 53
5.8.1 RESEARCH AND DEVELOPMENT 53
5.8.2 PROCUREMENT AND PRODUCT DEVELOPMENT 53
5.8.3 MARKETING, SALES & DISTRIBUTION, AND POST-SALES SERVICES 53
FIGURE 21 VALUE CHAIN ANALYSIS 53
5.9 SUPPLY CHAIN ANALYSIS 54
5.9.1 PROMINENT COMPANIES 54
5.9.2 SMALL & MEDIUM-SIZED COMPANIES 54
5.9.3 END USERS 54
FIGURE 22 SUPPLY CHAIN ANALYSIS 54
5.10 PATENT ANALYSIS 54
5.11 TRADE ANALYSIS 55
TABLE 7 IMPORT DATA FOR MICROCATHETERS (HS CODE 9018), BY COUNTRY, 2020–2022 (USD MILLION) 55
TABLE 8 EXPORT DATA FOR MICROCATHETERS (HS CODE 9018), BY COUNTRY, 2020–2022 (USD MILLION) 55
5.12 KEY CONFERENCES AND EVENTS IN 2022–2023 56
TABLE 9 MICROCATHETERS MARKET: DETAILED LIST OF MAJOR CONFERENCES AND EVENTS 56
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 56
FIGURE 23 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX 57
6 MICROCATHETER MARKET, BY PRODUCT 58
6.1 INTRODUCTION 59
TABLE 10 MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 59
TABLE 11 MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 59
TABLE 12 MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 60
TABLE 13 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 60
6.2 DELIVERY MICROCATHETERS 60
6.2.1 INCREASED NUMBER OF TARGET INTERVENTIONAL PROCEDURES TO DRIVE MARKET 60
TABLE 14 DELIVERY MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 61
TABLE 15 DELIVERY MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 61
TABLE 16 DELIVERY MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 62
TABLE 17 DELIVERY MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 62
6.3 ASPIRATION MICROCATHETERS 63
6.3.1 INCREASING BURDEN OF CARDIOVASCULAR DISEASES AND RELATED MEDICAL PROCEDURES TO AUGMENT MARKET 63
TABLE 18 ASPIRATION MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 63
TABLE 19 ASPIRATION MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 63
TABLE 20 ASPIRATION MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 64
TABLE 21 ASPIRATION MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 64
6.4 DIAGNOSTICS MICROCATHETERS 65
6.4.1 LARGE PATIENT POPULATION FOR VASCULAR DISEASES TO AID MARKET 65
TABLE 22 DIAGNOSTIC MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 65
TABLE 23 DIAGNOSTIC MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 65
TABLE 24 DIAGNOSTIC MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 66
TABLE 25 DIAGNOSTIC MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 66
6.5 STEERABLE MICROCATHETERS 67
6.5.1 GROWING NUMBER OF IMAGE-GUIDED AND MINIMALLY INVASIVE MEDICAL PROCEDURES TO BOOST MARKET 67
TABLE 26 STEERABLE MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 67
TABLE 27 STEERABLE MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 67
TABLE 28 STEERABLE MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 68
TABLE 29 STEERABLE MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 68
7 MICROCATHETERS MARKET, BY PRODUCT DESIGN 69
7.1 INTRODUCTION 70
TABLE 30 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 70
7.2 SINGLE LUMEN MICROCATHETERS 70
7.2.1 INCREASING NUMBER OF TARGET MEDICAL PROCEDURES AND OPERATIONAL ADVANTAGES TO PROPEL MARKET 70
TABLE 31 SINGLE LUMEN MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 71
7.3 DUAL-LUMEN MICROCATHETERS 71
7.3.1 PRODUCT ADVANTAGES AND INCREASED ADOPTION OF CATHETERS TO DRIVE MARKET 71
TABLE 32 DUAL-LUMEN MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 72
8 MICROCATHETERS MARKET, BY APPLICATION 73
8.1 INTRODUCTION 74
TABLE 33 MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 74
8.2 CARDIOVASCULAR APPLICATIONS 74
8.2.1 PROCEDURAL BENEFITS DURING CRITICAL CARDIAC SURGERIES TO AID MARKET 74
TABLE 34 MICROCATHETERS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 75
8.3 NEUROVASCULAR APPLICATIONS 75
8.3.1 INCREASING INCIDENCE OF TARGET NEUROLOGICAL CONDITIONS TO DRIVE MARKET 75
TABLE 35 MICROCATHETERS MARKET FOR NEUROVASCULAR APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 76
8.4 PERIPHERAL VASCULAR APPLICATION 76
8.4.1 RISING TARGET DIAGNOSTIC AND INTERVENTIONAL PROCEDURES TO STIMULATE MARKET 76
TABLE 36 MICROCATHETERS MARKET FOR PERIPHERAL VASCULAR APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 77
8.5 ONCOLOGY APPLICATIONS 77
8.5.1 INCREASING CLINICAL RESEARCH ON MINIMALLY INVASIVE CANCER TREATMENT TO DRIVE MARKET 77
TABLE 37 MICROCATHETERS MARKET FOR ONCOLOGY APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 78
9 MICROCATHETERS MARKET, BY END USER 79
9.1 INTRODUCTION 80
TABLE 38 MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 80
9.2 HOSPITALS, SURGICAL CENTERS, AND SPECIALTY CLINICS 80
9.2.1 LARGE NUMBER OF SURGICAL AND DIAGNOSTIC PROCEDURES TO PROPEL MARKET 80
TABLE 39 MICROCATHETERS MARKET FOR HOSPITALS, SURGICAL CENTERS, AND SPECIALTY CLINICS, BY REGION, 2020–2027 (USD MILLION) 81
9.3 AMBULATORY CARE CENTERS 81
9.3.1 LIMITED SURGICAL CAPABILITIES OF AVAILABLE PRODUCTS TO RESTRAIN ADOPTION 81
TABLE 40 MICROCATHETERS MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2020–2027 (USD MILLION) 82
10 MICROCATHETERS MARKET, BY REGION 83
10.1 INTRODUCTION 84
TABLE 41 MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 84
10.2 NORTH AMERICA 85
FIGURE 24 NORTH AMERICA: MARKET SNAPSHOT 85
TABLE 42 NORTH AMERICA: MICROCATHETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 85
TABLE 43 NORTH AMERICA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 86
TABLE 44 NORTH AMERICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 86
TABLE 45 NORTH AMERICA: MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 87
TABLE 46 NORTH AMERICA: MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 87
10.2.1 US 88
10.2.1.1 US to dominate North American market during forecast period 88
TABLE 47 US: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 88
10.2.2 CANADA 88
10.2.2.1 Increasing prevalence of target diseases and high demand for timely diagnosis to propel market 88
TABLE 48 CANADA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 89
10.3 EUROPE 89
TABLE 49 EUROPE: MICROCATHETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 89
TABLE 50 EUROPE: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 90
TABLE 51 EUROPE: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 90
TABLE 52 EUROPE: MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 90
TABLE 53 EUROPE: MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 91
10.3.1 GERMANY 91
10.3.1.1 Increasing aging population and rising life expectancy to boost market 91
TABLE 54 GERMANY: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 91
10.3.2 FRANCE 92
10.3.2.1 Significant evolution of healthcare sector to drive market 92
TABLE 55 FRANCE: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 92
10.3.3 UK 92
10.3.3.1 High burden of chronic diseases and large volume of surgeries to augment market 92
TABLE 56 UK: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 93
10.3.4 ITALY 93
10.3.4.1 Increasing geriatric population to aid growth 93
TABLE 57 ITALY: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 93
10.3.5 SPAIN 93
10.3.5.1 Increasing technological developments in healthcare sector to propel market 93
TABLE 58 SPAIN: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 94
10.3.6 REST OF EUROPE 94
TABLE 59 REST OF EUROPE: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 94
10.4 ASIA PACIFIC 95
FIGURE 25 ASIA PACIFIC: MARKET SNAPSHOT 95
TABLE 60 ASIA PACIFIC: MICROCATHETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 96
TABLE 61 ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 96
TABLE 62 ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 96
TABLE 63 ASIA PACIFIC: MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 97
TABLE 64 ASIA PACIFIC: MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 97
10.4.1 JAPAN 98
10.4.1.1 Increasing geriatric population and surgical procedures to drive market 98
TABLE 65 JAPAN: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 98
10.4.2 CHINA 99
10.4.2.1 Growing prevalence of chronic disorders and developing healthcare infrastructure to aid growth 99
TABLE 66 CHINA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 99
10.4.3 INDIA 100
10.4.3.1 Increasing target patient population with rising availability of advanced surgical treatments to drive market 100
TABLE 67 INDIA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 100
10.4.4 AUSTRALIA 100
10.4.4.1 Developing healthcare sector and increasing availability of advanced surgical treatments to stimulate market 100
TABLE 68 AUSTRALIA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 101
10.4.5 SOUTH KOREA 101
10.4.5.1 Growing target patient population for cardiovascular diseases to drive market 101
TABLE 69 SOUTH KOREA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 101
10.4.6 REST OF ASIA PACIFIC 102
TABLE 70 REST OF ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 102
10.5 LATIN AMERICA 102
10.5.1 FAVORABLE ECOSYSTEM FOR MEDICAL EQUIPMENT AND SUPPLIES TO DRIVE MARKET 102
TABLE 71 LATIN AMERICA: MICROCATHETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 103
TABLE 72 LATIN AMERICA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 103
TABLE 73 LATIN AMERICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 103
TABLE 74 LATIN AMERICA: MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 104
TABLE 75 LATIN AMERICA: MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 104
10.6 MIDDLE EAST & AFRICA 105
10.6.1 INCREASING FOCUS OF MARKET PLAYERS TO ESTABLISH THEIR PRESENCE TO PROPEL MARKET 105
TABLE 76 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 105
TABLE 77 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 106
TABLE 78 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 106
TABLE 79 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 106
11 COMPETITIVE LANDSCAPE 107
11.1 OVERVIEW 107
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 107
FIGURE 26 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MICROCATHETERS MARKET 108
11.3 MARKET RANKING ANALYSIS 109
FIGURE 27 MICROCATHETERS MARKET (2021) 109
11.3.1 BOSTON SCIENTIFIC CORPORATION 109
11.3.2 ASAHI INTECC CO., LTD. 110
11.3.3 MEDTRONIC PLC 110
11.3.4 TELEFLEX 110
11.3.5 TERUMO MEDICAL CORPORATION 111
11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 111
FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS IN MICROCATHETERS MARKET 111
11.5 COMPETITIVE BENCHMARKING OF TOP 26 PLAYERS 112
TABLE 80 OVERALL FOOTPRINT OF COMPANIES 112
TABLE 81 PRODUCT FOOTPRINT OF COMPANIES (26 COMPANIES) 113
TABLE 82 END USER FOOTPRINT OF COMPANIES (26 COMPANIES) 114
TABLE 83 REGIONAL FOOTPRINT OF COMPANIES (26 COMPANIES) 115
11.6 COMPANY EVALUATION QUADRANT 116
11.6.1 STARS 117
11.6.2 EMERGING LEADERS 117
11.6.3 PERVASIVE PLAYERS 117
11.6.4 PARTICIPANTS 117
FIGURE 29 MICROCATHETERS MARKET: COMPETITIVE LEADERSHIP MAPPING (2021) 118
11.7 START-UPS/SMES EVALUATION QUADRANT 118
11.7.1 PROGRESSIVE COMPANIES 118
11.7.2 DYNAMIC COMPANIES 118
11.7.3 STARTING BLOCKS 119
11.7.4 RESPONSIVE COMPANIES 119
FIGURE 30 MICROCATHETERS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2021) 119
11.8 COMPETITIVE SCENARIO 120
11.8.1 PRODUCT LAUNCHES AND APPROVALS 120
TABLE 84 PRODUCT LAUNCHES AND APPROVALS, 2019–2022 120
11.8.2 ALLIANCES, PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 121
TABLE 85 ALLIANCES, PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS, 2019–2022 121
12 COMPANY PROFILES 122
(Business Overview, Products/Services/Solutions offered, MnM view, Key strengths/right to win, Strategic choices made, Weakness/competitive threats)*
12.1 KEY PLAYERS 122
12.1.1 BOSTON SCIENTIFIC CORPORATION 122
TABLE 86 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 122
FIGURE 31 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2021) 123
12.1.2 ASAHI INTECC CO., LTD. 125
TABLE 87 ASAHI INTECC CO., LTD: COMPANY OVERVIEW 125
FIGURE 32 ASAHI INTECC CO., LTD.: COMPANY SNAPSHOT (2021) 125
12.1.3 MEDTRONIC PLC 127
TABLE 88 MEDTRONIC PLC: COMPANY OVERVIEW 127
FIGURE 33 MEDTRONIC PLC.: COMPANY SNAPSHOT (2021) 128
12.1.4 STRYKER 130
TABLE 89 STRYKER: COMPANY OVERVIEW 130
FIGURE 34 STRYKER: COMPANY SNAPSHOT (2021) 131
12.1.5 BECTON, DICKINSON AND COMPANY 133
TABLE 90 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 133
FIGURE 35 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021) 134
12.1.6 TERUMO MEDICAL CORPORATION 136
TABLE 91 TERUMO MEDICAL CORPORATION: COMPANY OVERVIEW 136
FIGURE 36 TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT (2021) 137
12.1.7 MERIT MEDICAL SYSTEMS, INC. 139
TABLE 92 MERIT MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW 139
FIGURE 37 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2021) 140
12.1.8 CARDINAL HEALTH 142
TABLE 93 CARDINAL HEALTH: COMPANY OVERVIEW 142
FIGURE 38 CARDINAL HEALTH: COMPANY SNAPSHOT (2021) 143
12.1.9 B. BRAUN MELSUNGEN AG 145
TABLE 94 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW 145
12.1.10 COOK MEDICAL GROUP 147
TABLE 95 COOK MEDICAL GROUP: COMPANY OVERVIEW 147
12.1.11 TELEFLEX 150
TABLE 96 TELEFLEX: COMPANY OVERVIEW 150
12.1.12 JOHNSON & JOHNSON 151
TABLE 97 JOHNSON & JOHNSON: COMPANY OVERVIEW 151
12.1.13 ANGIODYNAMICS 152
TABLE 98 ANGIODYNAMICS: COMPANY OVERVIEW 152
12.1.14 PENUMBRA 153
TABLE 99 PENUMBRA: COMPANY OVERVIEW 153
12.1.15 BTG PLC 154
TABLE 100 BTG PLC: COMPANY OVERVIEW 154
12.1.16 GUERBET LLC 155
TABLE 101 GUERBET LLC: COMPANY OVERVIEW 155
12.1.17 EMBOLX INC. 156
TABLE 102 EMBOLX INC.: COMPANY OVERVIEW 156
12.1.18 TOKAI MEDICAL 157
TABLE 103 TOKAI MEDICAL: COMPANY OVERVIEW 157
12.1.19 KANEKA CORPORATION 158
TABLE 104 KANEKA CORPORATION.: COMPANY SNAPSHOT 158
12.1.20 INTEGER HOLDINGS CORPORATION 159
TABLE 105 INTEGER HOLDINGS CORPORATION: COMPANY OVERVIEW 159
12.1.21 LIBATAPE PHARMACEUTICAL CO., LTD. 159
TABLE 106 LIBATAPE PHARMACEUTICAL CO., LTD.: COMPANY OVERVIEW 159
12.1.22 MICROVENTION TERUMO 160
TABLE 107 MICROVENTION TERUMO: COMPANY OVERVIEW 160
12.1.23 REFLOW MEDICAL 160
TABLE 108 REFLOW MEDICAL: COMPANY OVERVIEW 160
12.1.24 SPARTAN MICRO 161
TABLE 109 SPARTAN MICRO: COMPANY OVERVIEW 161
12.1.25 TRANSIT SCIENTIFIC 161
TABLE 110 TRANSIT SCIENTIFIC: COMPANY OVERVIEW 161
12.1.26 TRISALUS LIFE SCIENCES, INC. 162
TABLE 111 TRISALUS LIFE SCIENCES, INC.: COMPANY OVERVIEW 162
*Details on Business Overview, Products Offered, Recent Developments, Deals, MnM view, Key strengths/right to win, Strategic choices made, Weakness/competitive threats might not be captured in case of unlisted companies.
13 APPENDIX 163
13.1 DISCUSSION GUIDE 163
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 166
13.3 CUSTOMIZATION OPTIONS 168
13.4 RELATED REPORTS 168
13.5 AUTHOR DETAILS 169
